Chemical surface alteration of biodegradable magnesium exposed to corrosion media

Acta Biomaterialia

Volumn 7, Issue 6, 2011, Pages 2704-2715

  Willumeit, Regine ^a   Fischer, Janine ^a   Feyerabend, Frank ^a   Hort, Norbert ^a   Bismayer, Ulrich ^b   Heidrich, Stefanie ^b   Mihailova, Boriana ^b  

^a INSTITUTE OF MATERIALS RESEARCH   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Chemical element mapping; Corrosion layer; IR reflection microspectroscopy; Magnesium; Physiological corrosion

Indexed keywords

CARBON DIOXIDE; CELL CULTURE; ELECTROLYTES; MAPPING; OPTICAL EMISSION SPECTROSCOPY; PASSIVATION; PHYSIOLOGY; PROTEINS; SURFACE TREATMENT; ZINC;

CHEMICAL ELEMENT MAPPING; CHEMICAL SURFACES; CORROSION LAYERS; CORROSION MEDIUM; ELEMENT MAPPING; IR REFLECTION; IR REFLECTION MICROSPECTROSCOPY; MICRO SPECTROSCOPY; PHYSIOLOGICAL CORROSION; SURFACE ALTERATION;

MAGNESIUM;

CARBON DIOXIDE; ELECTROLYTE; MAGNESIUM; PROTEIN;

ARTICLE; BIODEGRADABLE IMPLANT; BLOOD; CELL GROWTH; CULTURE MEDIUM; FLAME PHOTOMETRY; INFRARED SPECTROSCOPY; ION PERMEABILITY; METAL IMPLANTATION; OSMOLALITY; PRIORITY JOURNAL; ROENTGEN SPECTROSCOPY; WATER PERMEABILITY;

EID: 79955581562     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2011.03.004     Document Type: Article

References (61)

1. Witte F, Hort N, Vogt C, Cohen S, Willumeit R, Kainer KU, et al. Current developments in biodegradable magnesium. Curr Opin Solid State Mater Sci 2008;12:63-72.
2. Zeng R, Dietzel W, Witte F, Hort N, Blawert C. Progress and challenge for magnesium alloys as biomaterials. Adv Eng Mater 2008;10:B3-B14.
3. Drynda A, Deinet N, Braun N, Peuster M. Rare earth metals used in biodegradable magnesium-based stents do not interfere with proliferation of smooth muscle cells but do induce the upregulation of inflammatory genes. J Biomed Mater Res A 2009;91A:360-9.
4. Kirkland NT, Lespagnol J, Birbilis N, Staiger MP. A survey of bio-corrosion rates of magnesium alloys. Corros Sci 2010;52:287-91.
5. Gu X, Zheng Y, Cheng Y, Zhong S, Xi T. In vitro corrosion and biocompatibility of binary magnesium alloys. Biomaterials 2009;30:484-98.
6. Hort N, Huang Y, Fechner D, Stormer M, Blawert C, Witte F, et al. Magnesium alloys as implant materials - principles of property design for Mg-RE alloys. Acta Biomater 2010;6:1714-25.
7. Li Z, Gu X, Lou S, Zheng Y. The development of binary Mg-Ca alloys for use as biodegradable materials within bone. Biomaterials 2008;29:1329-44.
8. Witte F, Feyerabend F, Maier P, Fischer J, Stormer M, Blawert C, et al. Biodegradable magnesium-hydroxyapatite metal matrix composites. Biomaterials 2007;28:2163-74. (Pubitemid 46216450)
9. Zhang S, Li J, Song Y, Zhao C, Zhang X, Xie C, et al. In vitro degradation, haemolysis and MC3T3-E1 cell adhesion of biodegradable Mg-Zn alloy. Mater Sci Eng C 2009;29:1907-12.
10. Hort N, Wolff M. Looking to the future: magnesium powder injection moulding. Powder Injection Mould Int 2008;2:63-5.
11. Wolff M, Ebel T, Dahms M. Sintering of magnesium. Adv Eng Mater 2010;12:829-36.
12. Ormiston JA, Serruys PW. Bioabsorbable coronary stents. Circ Cardiovasc Interv 2009;2:255-60.
13. Waksman RON. Update on bioabsorbable stents: from bench to clinical. J Interv Cardiol 2006;19:414-21.
14. Räber L, Windecker S. Current status of drug-eluting stents. Cardiovasc Ther 2010, doi:10.1111/j.1755-5922.2010.00144.x.
15. Raimund E, Carlo Di M, Jozef B, Johann B, Bernard de B, et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet 2007;369:1869-75.
16. Erbel R, Di Mario C, Bartunek J, Bonnier J, de Bruyne B, Eberli FR, et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet 2007;369:1869-75. (Pubitemid 46829357)
17. Feyerabend F, Fischer J, Holtz J, Witte F, Willumeit R, Drucker H, et al. Evaluation of short-term effects of rare earth and other elements used in magnesium alloys on primary cells and cell lines. Acta Biomater 2010;6:1834-42.
18. Feyerabend F, Witte F, Kammal M, Willumeit R. Unphysiologically high magnesium concentrations support chondrocyte proliferation and redifferentiation. Tissue Eng 2006;12:3545-56. (Pubitemid 46037176)
19. Zhang S, Zhang X, Zhao C, Li J, Song Y, Xie C, et al. Research on an Mg-Zn alloy as a degradable biomaterial. Acta Biomater 2010;6:626-40.
20. Witte F, Kaese V, Haferkamp H, Switzer E, Meyer-Lindenberg A, Wirth CJ, et al. In vivo corrosion of four magnesium alloys and the associated bone response. Biomaterials 2005;26:3557-63.
21. Witte F, Fischer J, Nellesen J, Crostack HA, Kaese V, Pisch A, et al. In vitro and in vivo corrosion measurements of magnesium alloys. Biomaterials 2006;27:1013-8.
22. Xu L, Yu G, Zhang E, Pan F, Yang K. In vivo corrosion behavior of Mg-Mn-Zn alloy for bone implant application. J Biomed Mater Res A 2007;83:703-11.
23. Zhang E, Xu L, Yu G, Pan F, Yang K. In vivo evaluation of biodegradable magnesium alloy bone implant in the first 6 months implantation. J Biomed Mater Res A 2009;90:882-93.
24. Müller W-D, Fernandez Lorenzo de Mele M, Nascimento ML, Zeddies M. Degradation of magnesium and its alloys: dependence on the composition of the synthetic biological media. J Biomed Mater Res 2008;90A:487-95.
25. Song G. Control of biodegradation of biocompatible magnesium alloys. Corros Sci 2007;49:1696-701. (Pubitemid 46365679)
26. Yamamoto A, Hiromoto S. Effect of inorganic salts, amino acids and proteins on the degradation of pure magnesium in vitro. Mater Sci Eng C 2009;29:1559-68.
27. Liu C, Xin Y, Tian X, Chu PK. Degradation susceptibility of surgical magnesium alloy in artificial biological fluid containing albumin. J Mater Res 2007;22:1806-14. (Pubitemid 47098562)
28. Rettig R, Virtanen S. Time-dependent electrochemical characterization of the corrosion of a magnesium rare-earth alloy in simulated body fluids. J Biomed Mater Res A 2008;85:167-75. (Pubitemid 351355366)
29. Fischer J, Prosenc MH, Wolff M, Hort N, Willumeit R, Feyerabend F. Interference of magnesium corrosion with tetrazolium-based cytotoxicity assays. Acta Biomater 2010;6:1813-23.
30. Lindström R, Johansson L-G, Thompson GE, Skeldon P, Svensson J-E. Corrosion of magnesium in humid air. Corros Sci 2004;46:1141-58. (Pubitemid 38398532)
31. Loudon R. The Raman effect in crystals. Adv Phys 1964;13:423-82.
32. Almeida RM. Detection of LO modes in glass by infrared reflection spectroscopy at oblique incidence. Phys Rev B 1992;45:161-70.
33. Müller WD, Lucia Nascimento M, Lorenzo de Mele MF. Critical discussion of the results from different corrosion studies of Mg and Mg alloys for biomaterial applications. Acta Biomater 2010;6:1749-55.
34. Braterman PS, Cygan RT. Vibrational spectroscopy of brucite: a molecular simulation investigation. Am Mineralogist 2006;91:1188-96. (Pubitemid 44203009)
35. Gu XN, Zheng YF, Chen LJ. Influence of artificial biological fluid composition on the biocorrosion of potential orthopedic Mg-Ca, AZ31, AZ91 alloys. Biomed Mater 2009;4:065011.
36. Xu L, Zhang E, Yin D, Zeng S, Yang K. In vitro corrosion behaviour of Mg alloys in a phosphate buffered solution for bone implant application. J Mater Sci Mater Med 2008;19:1017-25.
37. Staiger MP, Pietak AM, Huadmai J, Dias G. Magnesium and its alloys as orthopedic biomaterials: a review. Biomaterials 2006;27:1728-34. (Pubitemid 41760433)
38. Xin Y, Huo K, Tao H, Tang G, Chu PK. Influence of aggressive ions on the degradation behavior of biomedical magnesium alloy in physiological environment. Acta Biomater 2008;4:2008-15.
39. Silbernagl S, Despopoulos A. Taschenatlas der Physiologie. Stuttgart: Georg Thieme Verlag KG; 2007.
40. Tie D, Feyerabend F, Hort N, Willumeit R, Hoeche D. XPS studies of magnesium surfaces after exposure to Dulbecco's modified Eagle medium, Hank's buffered salt solution, and simulated body fluid. Adv Eng Mater 2010;12:B699-704.
41. Beardmore J, Exley C. Towards a model of non-equilibrium binding of metal ions in biological systems. J Inorg Biochem 2009;103:205-9.
42. Huang BX, Kim H-Y, Dass C. Probing three-dimensional structure of bovine serum albumin by chemical cross-linking and mass spectrometry. J Am Soc Mass Spectrosc 2004;15:1237-47. (Pubitemid 38970068)
43. Kosa T, Maruyama T, Otagiri M. Species differences of serum albumins: I. Drug binding sites. Pharm Res 1997;14:1607-12.
44. Michnik A, Michalik K, Kluczewska A, Drzazga Z. Comparative DSC study of human and bovine serum albumin. J Thermal Anal Calorim 2006;84:113-7.
45. Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. Pharmacol Rev 1981;33:17-53.
46. Kragh-Hansen U. Structure and ligand binding properties of human serum albumin. Dan Med Bull 1990;37:57-84.
47. Vorum H, Fisker K, Otagiri M, Pedersen A, Kragh-Hansen U. Calcium ion binding to clinically relevant chemical modifications of human serum albumin. Clin Chem 1995;41:1654-61.
48. Pedersen KO. Binding of calcium to serum albumin. I. Stoichiometry and intrinsic association constant at physiological pH, ionic strength, and temperature. Scand J Clin Lab Invest 1971;28:459-69.
49. Kragh-Hansen U, Brennan SO, Minchiotti L, Galliano M. Modified high-affinity binding of Ni2+, Ca2+ and Zn2+ to natural mutants of human serum albumin and proalbumin. Biochem J 1994;301:217-23.
50. Pedersen KO. Binding of calcium to serum albumin. III. Influence of ionic strength and ionic medium. Scand J Clin Lab Invest 1972;29:427-32.
51. Kragh-Hansen U, Vorum H. Quantitative analyses of the interaction between calcium ions and human serum albumin. Clin Chem 1993;39:202-8. (Pubitemid 23069673)
52. Guillaume YC, Guinchard C, Berthelot A. Affinity chromatography study of magnesium and calcium binding to human serum albumin: pH and temperature variations. Talanta 2000;53:561-9.
53. Guillaume YC, Peyrin E, Berthelot A. Chromatographic study of magnesium and calcium binding to immobilized human serum albumin. J Chromatogr B Biomed Sci Appl 1999;728:167-74. (Pubitemid 29248859)
54. Copeland BE, Sunderman FW. Studies in serum electrolytes. XVIII. The magnesium-binding property of the serum proteins. J Biol Chem 1952;197:331-41.
55. Fogh-Andersen N. Albumin/calcium association at different pH, as determined by potentiometry. Clin Chem 1977;23:2122-6. (Pubitemid 8220656)
56. van Os GAJ, Koopman-van Eupen JHM. The interaction of sodium, potassium, calcium, and magnesium with human serum albumin, studied by means of conductivity measurements. Recueil des Travaux Chimiques des Pays-Bas 1957;76:390-400.
57. Frye RM, Lees H, Rechnitz GA. Magnesium-albumin binding measurements using ion-selective membrane electrodes. Clin Biochem 1974;7:258-70.
58. Pedersen KO. Binding of calcium to serum albumin. II. Effect of pH via competitive hydrogen and calcium ion binding to the imidazole groups of albumin. Scand J Clin Lab Invest 1972;29:75-83.
59. Pedersen KO. Binding of calcium to serum albumin. IV. Effect of temperature and thermodynamics of calcium-albumin interaction. Scand J Clin Lab Invest 1972;30:89-94.
60. Liu CL, Wang YJ, Zeng RC, Zhang XM, Huang WJ, Chu PK. In vitro corrosion degradation behaviour of Mg-Ca alloy in the presence of albumin. Corros Sci 2010;52:3341-7.
61. Merritt K, Brown SA, Sharkey NA. The binding of metal salts and corrosion products to cells and proteins in vitro. J Biomed Mater Res 1984;18:1005-15. (Pubitemid 15425884)